MedPath

VYNDAQEL 61 MG CAPSULAS BLANDAS

VYNDAQEL 61 MG CAPSULAS BLANDAS

Commercialized
Register Number

1110717003

Prescription Type

Uso Hospitalario

Authorization Date

Mar 31, 2020

Dosage Form

CÁPSULA BLANDA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1110717003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

TAFAMIDISActive
Quantity: 61 mg
Name: TAFAMIDIS

ATC CLASSIFICATION (3)

N07X
N07XX
N07XX08

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.